Radar mondial UDTR

UDTR — Radar mondial des droits de la Nature

Registre documentaire des références détectées à travers les infrastructures académiques, juridiques et institutionnelles surveillées par UDTR.

Une infrastructure documentaire mondiale conçue pour atteindre la couverture la plus large, vérifiable et scientifiquement défendable des droits de la Nature.

← Retour au Radar

Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform

Identification

Clé publique
radar:r-c371958624f788ce6e32f9326e8e11c5
Auteurs
Annamaria Sapuppo · Grete Francesca Privitera · Vincenzo Sortino · Piero Pavone · Agata Polizzi · Martino Ruggieri · Raffaele Falsaperla
Année déclarée
2026
Langue déclarée
en
Type source
article
Première détection
2026-11-13T12:45:48.187438+00:00
Dernière observation des métadonnées
2026-11-13T12:45:48.187438+00:00
Dernière vérification HTTP
Non effectuée

Institutions déclarées par la source

University of Catania · Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" · Università degli Studi di Enna Kore · Institute for Biomedical Research and Innovation · National Research Council · University of Ferrara

Pays d’affiliation déclarés

IT

Résumé documentaire — langue originale

BACKGROUND: The diagnosis of mitochondrial disorders (MDs) in pediatric patients is complex and often delayed due to heterogeneous clinical presentations and limited access to invasive confirmation tests such as muscle biopsy. OBJECTIVE: To evaluate the diagnostic sensitivity and specificity of a targeted next-generation sequencing (NGS) panel (Blueprint Genetics® “FLEX Comprehensive Epilepsy Panel Plus”) for detecting MDs in a cohort of pediatric patients with neurological symptoms compared with gold standard tissue biopsy and clinical follow-up. The primary endpoint was the diagnostic accuracy of targeted NGS panel testing for pediatric MDs. The secondary endpoints were the identification of clinical predictors and biochemical correlations associated with increased diagnostic yield and the assessment of age-dependent diagnostic patterns. METHODS: We enrolled 36 pediatric patients between May 2022 and July 2023 on the basis of predefined clinical criteria suggestive of MDs. All patients underwent buccal swab-based targeted NGS testing. Confirmatory tissue biopsies and functional studies were performed in selected cases as the gold standard reference. True positives were defined as pathogenic/likely pathogenic variants confirmed by tissue biopsy and/or strong clinical correlation. Statistical analyses included Pearson correlation, Fisher’s exact test, and univariate logistic regression, stratifying data by age of onset and clinical features. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines to ensure methodological rigor and transparency. This was a convenience sample without a priori power calculation. RESULTS: Five patients (5/34 out of 36 patients who completed the study, 14.7%) harbored variants in MD-associated genes. Pathogenic or likely pathogenic variants were confirmed in three cases through tissue biopsy, acting as true positives. The sensitivity was 100% (95% CI: 29.2–100%), the specificity was 94% (95% CI: 79.6–99.3%), the accuracy was 94% (95% CI: 80.3–99.3%), and the positive predictive value was 60% (95% CI: 14.7–94.7%). The positive predictive value reflects the presence of variants of uncertain significance (VUS) requiring further validation. Statistically significant correlations were observed between the presence of MD variants and elevated blood lactate (R = 0.51, p < 0.05) and GGT levels (R = 0.46, p < 0.05) and reduced hemoglobin (R=-0.42, p < 0.05). Eight specific clinical signs, occurring at < 12 months of age, strongly predicted MD-related variants with statistical significance (p < 0.05). CONCLUSION: Targeted NGS via buccal swabs demonstrates high accuracy and specificity in diagnosing pediatric MDs when guided by a structured clinical phenotype and confirmed by tissue analysis. Early onset of specific clinical signs should prompt NGS testing and may reduce unnecessary invasive procedures. Early diagnosis enables improved patient management and family counseling.

Identifiants

OPENALEX
https://openalex.org/W7152855506
DOI
10.1186/s13023-026-04213-9
PMID
https://pubmed.ncbi.nlm.nih.gov/41957679
PMCID
https://www.ncbi.nlm.nih.gov/pmc/articles/13067512

Repères documentaires

Famille documentaire
article
Types déclarés par les sources
article
Éditeurs
BioMed Central

Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.

Sources

OpenAlex · Document 1

Citer cette référence

Annamaria Sapuppo; Grete Francesca Privitera; Vincenzo Sortino; Piero Pavone; Agata Polizzi; Martino Ruggieri; Raffaele Falsaperla. Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform. 2026. https://doi.org/10.1186/s13023-026-04213-9

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.

APA
Annamaria Sapuppo; Grete Francesca Privitera; Vincenzo Sortino; Piero Pavone; Agata Polizzi; Martino Ruggieri; Raffaele Falsaperla. (2026). Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform. https://doi.org/10.1186/s13023-026-04213-9
Chicago
Annamaria Sapuppo; Grete Francesca Privitera; Vincenzo Sortino; Piero Pavone; Agata Polizzi; Martino Ruggieri; Raffaele Falsaperla. Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform. 2026. https://doi.org/10.1186/s13023-026-04213-9
ISO 690
Annamaria Sapuppo; Grete Francesca Privitera; Vincenzo Sortino; Piero Pavone; Agata Polizzi; Martino Ruggieri; Raffaele Falsaperla. Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform. 2026. https://doi.org/10.1186/s13023-026-04213-9

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR — Bibliothèque juridique mondiale des droits de la Nature. Diagnosis of pediatric mitochondrial diseases via targeted next-generation sequencing (NGS): real-world data with the Blueprint Genetics® platform. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-c371958624f788ce6e32f9326e8e11c5/ · Dernière vérification HTTP : non effectuée

Signaler une correction

Données de cette version figée

Dossiers et relations documentaires

Rôles des sources

Source bibliographique / publication d’origine · https://doi.org/10.1186/s13023-026-04213-9

Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.

Statut documentaire

Pertinence à examiner

Bibliothèque

Cette identité n’est pas encore intégrée à la Bibliothèque juridique.

UDTR — Bibliothèque juridique mondiale des droits de la Nature